| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.085 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |